Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabien Calvo

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
The EMBO Journal|April 24, 2009
The antiapoptotic protein AAC-11 interacts with and regulates Acinus-mediated DNA fragmentationPatricia Rigou, Valeria Piddubnyak, Audrey Faye, et al.
Leukemia Research|May 15, 2002
Potential mechanisms of resistance to cytarabine in AML patientsCarlos M Galmarini, Xavier Thomas, Fabien Calvo, et al.
Cancer Research|October 3, 2007
Opposing function of the proprotein convertases furin and PACE4 on breast cancer cells' malignant phenotypes: role of tissue inhibitors of metalloproteinase-1Marion Lapierre, Geraldine Siegfried, Nathalie Scamuffa, et al.
Journal of Vascular Surgery|December 19, 2003
Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcersPatricia Senet, François-Xavier Bon, Marc Benbunan, et al.
Seminars in Oncology|August 8, 2006
Preclinical and clinical development of novel agents that target the protein kinase C familyMaria Serova, Aïda Ghoul, Karim A Benhadji, et al.
British Journal of Haematology|June 13, 2002
In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemiaCarlos M Galmarini, Xavier Thomas, Fabien Calvo, et al.
International Journal of Cancer|May 18, 2004
Receptor for the globular heads of C1q (gC1q-R, p33, hyaluronan-binding protein) is preferentially expressed by adenocarcinoma cellsDaniel B Rubinstein, Alexei Stortchevoi, Michael Boosalis, et al.
Current Pharmaceutical Biotechnology|April 9, 2008
In silico-in vitro screening of protein-protein interactions: towards the next generation of therapeuticsBruno O Villoutreix, Karine Bastard, Olivier Sperandio, et al.
The Journal of Clinical Investigation|December 8, 2007
Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cellsNathalie Scamuffa, Geraldine Siegfried, Yannick Bontemps, et al.
Experimental Cell Research|November 28, 2006
Platelets, thrombospondin-1 and human dermal fibroblasts cooperate for stimulation of endothelial cell tubulogenesis through VEGF and PAI-1 regulationSabrina Kellouche, Samia Mourah, Arnaud Bonnefoy, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
The EMBO Journal|April 24, 2009
The antiapoptotic protein AAC-11 interacts with and regulates Acinus-mediated DNA fragmentationPatricia Rigou, Valeria Piddubnyak, Audrey Faye, et al.
Leukemia Research|May 15, 2002
Potential mechanisms of resistance to cytarabine in AML patientsCarlos M Galmarini, Xavier Thomas, Fabien Calvo, et al.
Cancer Research|October 3, 2007
Opposing function of the proprotein convertases furin and PACE4 on breast cancer cells' malignant phenotypes: role of tissue inhibitors of metalloproteinase-1Marion Lapierre, Geraldine Siegfried, Nathalie Scamuffa, et al.
Journal of Vascular Surgery|December 19, 2003
Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcersPatricia Senet, François-Xavier Bon, Marc Benbunan, et al.
Seminars in Oncology|August 8, 2006
Preclinical and clinical development of novel agents that target the protein kinase C familyMaria Serova, Aïda Ghoul, Karim A Benhadji, et al.
British Journal of Haematology|June 13, 2002
In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemiaCarlos M Galmarini, Xavier Thomas, Fabien Calvo, et al.
International Journal of Cancer|May 18, 2004
Receptor for the globular heads of C1q (gC1q-R, p33, hyaluronan-binding protein) is preferentially expressed by adenocarcinoma cellsDaniel B Rubinstein, Alexei Stortchevoi, Michael Boosalis, et al.
Current Pharmaceutical Biotechnology|April 9, 2008
In silico-in vitro screening of protein-protein interactions: towards the next generation of therapeuticsBruno O Villoutreix, Karine Bastard, Olivier Sperandio, et al.
The Journal of Clinical Investigation|December 8, 2007
Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cellsNathalie Scamuffa, Geraldine Siegfried, Yannick Bontemps, et al.
Experimental Cell Research|November 28, 2006
Platelets, thrombospondin-1 and human dermal fibroblasts cooperate for stimulation of endothelial cell tubulogenesis through VEGF and PAI-1 regulationSabrina Kellouche, Samia Mourah, Arnaud Bonnefoy, et al.
Pageof 9